Bank Of New York Mellon Corp Gilead Sciences, Inc. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$77.31 - $88.08 $1.32 Billion - $1.5 Billion	17,012,204 New	17,012,204 $0
Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $1.03 Billion - $1.48 Billion	16,545,609 New	16,545,609 $1.42 Billion
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $118 Million - $135 Million	1,987,058 Added 14.79%	15,421,436 $951 Million
Q2 2022 Aug 15, 2022	BUY	$57.72 - $65.01 $42.4 Million - $47.7 Million	733,944 Added 5.78%	13,434,378 $830 Million
Q1 2022 May 11, 2022	SELL	$57.92 - $72.58 $15 Million - $18.9 Million	-259,813 Reduced 2.0%	12,700,434 $755 Million
Q4 2021 Feb 11, 2022	BUY	$64.88 - $73.64 $19.4 Million - $22.1 Million	299,457 Added 2.37%	12,960,247 $941 Million
Q3 2021 Nov 12, 2021	SELL	$67.69 - $73.03 $1.96 Million - $2.11 Million	-28,960 Reduced 0.23%	12,660,790 $884 Million
Q2 2021 Aug 11, 2021	SELL	$63.47 - $69.35 $23.2 Million - $25.4 Million	-365,837 Reduced 2.8%	12,689,750 $874 Million
Q1 2021 May 13, 2021	SELL	$60.0 - $68.46 $45.1 Million - $51.4 Million	-750,945 Reduced 5.44%	13,055,587 $844 Million
Q4 2020 Feb 09, 2021	SELL	$56.65 - $64.55 $149 Million - $169 Million	-2,625,006 Reduced 15.98%	13,806,532 $804 Million
Q3 2020 Nov 12, 2020	SELL	$62.1 - $78.08 $26.2 Million - $33 Million	-422,143 Reduced 2.5%	16,431,538 $1.04 Billion
Q2 2020 Aug 12, 2020	SELL	$72.34 - $84.0 $150 Million - $174 Million	-2,072,078 Reduced 10.95%	16,853,681 $1.3 Billion
Q1 2020 May 06, 2020	SELL	$62.63 - $80.22 $635 Million - $814 Million	-10,142,225 Reduced 34.89%	18,925,759 $1.41 Billion
Q4 2019 Feb 14, 2020	BUY	$61.62 - $67.78 $53.7 Million - $59 Million	870,944 Added 3.09%	29,067,984 $1.89 Billion
Q3 2019 Nov 07, 2019	SELL	$62.51 - $69.0 $13.2 Million - $14.5 Million	-210,504 Reduced 0.74%	28,197,040 $1.79 Billion
Q2 2019 Aug 12, 2019	SELL	$61.87 - $69.38 $51.5 Million - $57.7 Million	-832,136 Reduced 2.85%	28,407,544 $1.92 Billion
Q1 2019 May 14, 2019	BUY	$62.53 - $70.05 $44.4 Million - $49.8 Million	710,832 Added 2.49%	29,239,680 $1.9 Billion
Q4 2018 Feb 11, 2019	SELL	$60.54 - $79.0 $171 Million - $223 Million	-2,821,866 Reduced 9.0%	28,528,848 $1.78 Billion
Q3 2018 Nov 09, 2018	BUY	$71.28 - $78.92 $2.23 Billion - $2.47 Billion	31,335,030 Added 199789.8%	31,350,714 $0
Q2 2018 Aug 24, 2018	SELL	$64.88 - $75.68 $2.01 Billion - $2.34 Billion	-30,921,286 Reduced 99.95%	15,684 $1.11 Million
Q2 2018 Aug 06, 2018	BUY	$64.88 - $75.68 $209 Million - $244 Million	3,221,439 Added 11.62%	30,936,970 $2.19 Billion
Q1 2018 May 15, 2018	SELL	$72.84 - $88.8 $206 Million - $251 Million	-2,827,397 Reduced 9.26%	27,715,531 $2.09 Billion
Q4 2017 Feb 09, 2018	BUY	$71.15 - $83.52 $2.17 Billion - $2.55 Billion	30,542,928	30,542,928 $2.19 Billion

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.1 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.07 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.71 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.56 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account